1. Home
  2. ASMB vs TMQ Comparison

ASMB vs TMQ Comparison

Compare ASMB & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$22.95

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Logo Trilogy Metals Inc.

TMQ

Trilogy Metals Inc.

N/A

Current Price

$3.07

Market Cap

579.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
TMQ
Founded
2005
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
579.8M
IPO Year
2010
2012

Fundamental Metrics

Financial Performance
Metric
ASMB
TMQ
Price
$22.95
$3.07
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
★ $52.00
$6.52
AVG Volume (30 Days)
292.3K
★ 1.1M
Earning Date
11-09-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.78
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.80
$2.03
52 Week High
$39.71
$11.29

Technical Indicators

Market Signals
Indicator
ASMB
TMQ
Relative Strength Index (RSI) 27.24 37.87
Support Level $21.80 $2.83
Resistance Level $30.36 $3.28
Average True Range (ATR) 1.22 0.13
MACD -0.41 -0.02
Stochastic Oscillator 1.75 4.65

Price Performance

Historical Comparison
ASMB
TMQ

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the USA. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: